<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141659908388750%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201902032%26RESULT%3d1%26SIGN%3dHv0Ux0LK0at4ojCFqJkp%252fhGVmzc%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902032&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902032&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902032&amp;v=MDg5MDlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WTDNOUFRYTVpiRzRIOWpNclk5R1pvUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#56" data-title="&lt;b&gt;1&lt;/b&gt; CHD-PAH&lt;b&gt;诊断标准及分型&lt;/b&gt; "><b>1</b> CHD-PAH<b>诊断标准及分型</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#59" data-title="&lt;b&gt;2&lt;/b&gt; CHD-PAH&lt;b&gt;自然病程与预后&lt;/b&gt; "><b>2</b> CHD-PAH<b>自然病程与预后</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#60" data-title="2.1 艾森曼格综合征 (ES) ">2.1 艾森曼格综合征 (ES) </a></li>
                                                <li><a href="#62" data-title="2.2 左向右分流先心病">2.2 左向右分流先心病</a></li>
                                                <li><a href="#64" data-title="2.3 肺动脉高压合并先心病">2.3 肺动脉高压合并先心病</a></li>
                                                <li><a href="#66" data-title="2.4 术后肺动脉高压">2.4 术后肺动脉高压</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#68" data-title="&lt;b&gt;3 影响&lt;/b&gt;CHD-PAH&lt;b&gt;预后的相关因素&lt;/b&gt; "><b>3 影响</b>CHD-PAH<b>预后的相关因素</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#70" data-title="3.1 血清C反应蛋白对患者预后的影响">3.1 血清C反应蛋白对患者预后的影响</a></li>
                                                <li><a href="#72" data-title="3.2 高敏肌钙蛋白T (hsTnT) 对患者预后的影响">3.2 高敏肌钙蛋白T (hsTnT) 对患者预后的影响</a></li>
                                                <li><a href="#74" data-title="3.3 BNP和 NT-proBNP对CHD-PAH患者预后的影响">3.3 BNP和 NT-proBNP对CHD-PAH患者预后的影响</a></li>
                                                <li><a href="#76" data-title="3.4 部分超声心动图数值对CHD-PAH病人预后的影响">3.4 部分超声心动图数值对CHD-PAH病人预后的影响</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#78" data-title="&lt;b&gt;4 靶向药物对&lt;/b&gt;CHD-PAH&lt;b&gt;患者预后的影响&lt;/b&gt; "><b>4 靶向药物对</b>CHD-PAH<b>患者预后的影响</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#80" data-title="&lt;b&gt;5 小 结&lt;/b&gt; "><b>5 小 结</b></a><i></i></p>
                                                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="3">


                                    <a id="bibliography_1" title="Frank DB, Hanna BD.Pulmonary arterial hypertension associated with congenital heart dIsease and eisenmenger syndrome:current practice in pediatrics[J].Minerva Pediatr, 2015, 67 (2) ;169-185." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Pulmonary arterial hypertension associated with congenital heart disease and eisenmenger syndrome:Current practice in pediatrics">
                                        <b>[1]</b>
                                        Frank DB, Hanna BD.Pulmonary arterial hypertension associated with congenital heart dIsease and eisenmenger syndrome:current practice in pediatrics[J].Minerva Pediatr, 2015, 67 (2) ;169-185.
                                    </a>
                                </li>
                                <li id="5">


                                    <a id="bibliography_2" title="Todds, Roth MD, Jamil A.Pulmonary Hypertension and Congenital Heart disease[J].Cardial Clin, 2016, 34:391-400." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Pulmonary Hypertension and Congenital Heart disease">
                                        <b>[2]</b>
                                        Todds, Roth MD, Jamil A.Pulmonary Hypertension and Congenital Heart disease[J].Cardial Clin, 2016, 34:391-400.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_3" title="van Riel AC, Schuuring MJ, van Hessen ID, et al.Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification[J].Int J Cardiol, 2014, 174 (2) :299-305." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14061600103106&amp;v=MzIyMDlNbndaZVp0RmlubFVyZklJRjBUYUJjPU5pZk9mYks4SHRmTnFZOUZaZXNNRFh3L29CTVQ2VDRQUUgvaXJSZEdlcnFRVA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        van Riel AC, Schuuring MJ, van Hessen ID, et al.Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification[J].Int J Cardiol, 2014, 174 (2) :299-305.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_4" title="Ramjug S, Hussain N, Hurdman J, et al.Pulmonary arterial hypertension associated with congenital heart disease:Comparison of clinical and anatomic-pathophysiologic classification[J].J Heart Lung Transplant, 2016, 35 (5) :610-618." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Pulmonary arterial hypertension associated with congenital heart disease:Comparison of clinical and anatomic-pathophysiologic classification">
                                        <b>[4]</b>
                                        Ramjug S, Hussain N, Hurdman J, et al.Pulmonary arterial hypertension associated with congenital heart disease:Comparison of clinical and anatomic-pathophysiologic classification[J].J Heart Lung Transplant, 2016, 35 (5) :610-618.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_5" title="5&lt;sup&gt;th &lt;/sup&gt;world symposium on Pulmonary Hypertension, Nice, 2013." target="_blank"
                                       href="">
                                        <b>[5]</b>
                                        5&lt;sup&gt;th &lt;/sup&gt;world symposium on Pulmonary Hypertension, Nice, 2013.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_6" title="Beghetti M, Gali&#232; N.Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension[J].J Am Coll Cardiol, 2009, 53 (9) :733-740." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100340574&amp;v=MDk3NTgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhQmM9TmlmT2ZiSzdIdERPcm85RlorOFBDWHM5b0JNVDZUNFBRSA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        Beghetti M, Gali&#232; N.Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension[J].J Am Coll Cardiol, 2009, 53 (9) :733-740.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_7" title="Diller GP, Dimopoulos K, Broberg CS, et al.Presentation, survival prospects, and predictors of death in Eisenmenger syndrome:a combined retrospective and case-control study[J].Eur Heart J, 2006, 27 (14) :1737-1742." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study">
                                        <b>[7]</b>
                                        Diller GP, Dimopoulos K, Broberg CS, et al.Presentation, survival prospects, and predictors of death in Eisenmenger syndrome:a combined retrospective and case-control study[J].Eur Heart J, 2006, 27 (14) :1737-1742.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_8" >
                                        <b>[8]</b>
                                    Barst RJ, Ivy DD, Foreman AJ, et al.Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry) [J].Am J Cardiol, 2014, 113 (1) :147-155.</a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_9" title="Diller GP, Dimopoulos K, Okonko D, et al.Exercise intolerance in adult congenital heart disease:comparative severity, correlates, and prognostic implication[J].Circulation, 2005, 112 (6) :828-835." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000032558&amp;v=MjQyMjE0OUZaT2dOQ1hreG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhQmM9TmlmY1piSzZIOUhQcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        Diller GP, Dimopoulos K, Okonko D, et al.Exercise intolerance in adult congenital heart disease:comparative severity, correlates, and prognostic implication[J].Circulation, 2005, 112 (6) :828-835.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_10" >
                                        <b>[10]</b>
                                    Manes A, Palazzini M, Leci E, et al.Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease:a comparison between clinical subgroups[J].Eur Heart J, 2014, 35 (11) :716-724.</a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_11" title="Alonso-Gonzalez R, Lopez-Guarch CJ, Subirana-Domenech MT, et al.Pulmonary hypertension and congenital heart disease:An insight from the REHAP National Registry[J].Int J Cardiol, 2015, 184:717-723." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122500347100&amp;v=MTg1ODhvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYUJjPU5pZk9mYks5SDlQT3FvOUZaKzhJRFh3NQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        Alonso-Gonzalez R, Lopez-Guarch CJ, Subirana-Domenech MT, et al.Pulmonary hypertension and congenital heart disease:An insight from the REHAP National Registry[J].Int J Cardiol, 2015, 184:717-723.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_12" title="Manes A, Palazzini M, Leci E, et al.Current era survival of patients with pulmonary arterial hypertension associated withcongenital heart disease:a comparison between clinical subgroups[J].Eur Heart J, 2014, 35 (11) :716-724." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease:a comparison between clinical subgroups">
                                        <b>[12]</b>
                                        Manes A, Palazzini M, Leci E, et al.Current era survival of patients with pulmonary arterial hypertension associated withcongenital heart disease:a comparison between clinical subgroups[J].Eur Heart J, 2014, 35 (11) :716-724.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_13" >
                                        <b>[13]</b>
                                    Scognamiglio G, Kempny A, Price LC, et al.C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value[J].Heart, 2014, 100 (17) :1335-1341.</a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_14" title="Schuuring MJ, van Riel AC, Vis JC, et al.High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease[J].Congenit Heart Dis, 2013, 8 (6) :520-526" target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD13120900000453&amp;v=MDY0MjI0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYUJjPU5pZmNhcks3SDlQTXBvOUZaT3NQQ0hrNm9CTVQ2VA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        Schuuring MJ, van Riel AC, Vis JC, et al.High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease[J].Congenit Heart Dis, 2013, 8 (6) :520-526
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_15" title="Maeda K, Tsutamoto T, Wada A, et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction[J].Am Heart J, 1998, 135 (SPt 1) :825-832." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702187489&amp;v=MjQ5NDZmSUlGMFRhQmM9TmlmT2ZiSzdIdEROcUk5SFplTUlDSFF3b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        Maeda K, Tsutamoto T, Wada A, et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction[J].Am Heart J, 1998, 135 (SPt 1) :825-832.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_16" title="Reardon LC, Williams RJ, Houser LS, et al.Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome[J].Am J Cardiol, 2012, 110 (10) :1523-1526." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702166217&amp;v=Mjc1MDYvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhQmM9TmlmT2ZiSzdIdEROcUk5SFplMEpEbjArb0JNVDZUNFBRSA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[16]</b>
                                        Reardon LC, Williams RJ, Houser LS, et al.Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome[J].Am J Cardiol, 2012, 110 (10) :1523-1526.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_17" title="Diller G-P, Alonso-Gonzalez R, Kempny A, et al.B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients:predictive value and response to disease targeting therapy[J].Heart, 2012, 98 (19) :736-742." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy">
                                        <b>[17]</b>
                                        Diller G-P, Alonso-Gonzalez R, Kempny A, et al.B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients:predictive value and response to disease targeting therapy[J].Heart, 2012, 98 (19) :736-742.
                                    </a>
                                </li>
                                <li id="37">


                                    <a id="bibliography_18" title="Barst RJ, Ivy DD, Foreman AJ, et al.Four- and seven-year outcomes of patients with congenital heart disease — associated pulmonary arterial hypertension (from the REVEAL registry) [J].Am J Cardiol, 2014, 113 (1) :147-155." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15120400079031&amp;v=MTMwMzBxUVRNbndaZVp0RmlubFVyZklJRjBUYUJjPU5pZk9mYks5SDlQTXE0OUZaT3dHREg4NG9CTVQ2VDRQUUgvaXJSZEdlcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[18]</b>
                                        Barst RJ, Ivy DD, Foreman AJ, et al.Four- and seven-year outcomes of patients with congenital heart disease — associated pulmonary arterial hypertension (from the REVEAL registry) [J].Am J Cardiol, 2014, 113 (1) :147-155.
                                    </a>
                                </li>
                                <li id="39">


                                    <a id="bibliography_19" title="Schuuring MJ, van Riel AC, Vis JC, et al.New predictors of mortality in adults with congenital heart disease and pulmonary hypertension:Midterm outcome of a prospective study[J].Int J Cardiol, 2015, 181 () :270-276." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122500346832&amp;v=MTY0MTNCTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhQmM9TmlmT2ZiSzlIOVBPcW85RlorOEpCSDg3bw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[19]</b>
                                        Schuuring MJ, van Riel AC, Vis JC, et al.New predictors of mortality in adults with congenital heart disease and pulmonary hypertension:Midterm outcome of a prospective study[J].Int J Cardiol, 2015, 181 () :270-276.
                                    </a>
                                </li>
                                <li id="41">


                                    <a id="bibliography_20" title="Moceri P, Dimopoulos K, Liodakis E, et al.Echocardiographic predictors of outcome in Eisenmenger syndrome[J].Circulation, 2012, 126 (12) :1461-1468." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK120927000383&amp;v=MjkxNjhaZVp2RnludFU3L0xKMXdSTmlmY1piSzZIdGpPcUk5RlpPZ0hEeE04enhVU21EZDlTSDduM3hFOWZidm5Lcmlm&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[20]</b>
                                        Moceri P, Dimopoulos K, Liodakis E, et al.Echocardiographic predictors of outcome in Eisenmenger syndrome[J].Circulation, 2012, 126 (12) :1461-1468.
                                    </a>
                                </li>
                                <li id="43">


                                    <a id="bibliography_21" title="D′Alto M, Dimopoulos K, Budts W, et al.Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension[J].Heart, 2016, 102 (12) :910-918." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension">
                                        <b>[21]</b>
                                        D′Alto M, Dimopoulos K, Budts W, et al.Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension[J].Heart, 2016, 102 (12) :910-918.
                                    </a>
                                </li>
                                <li id="45">


                                    <a id="bibliography_22" title="Thomas IC, Glassner-Kolmin C, Gomberg-Maitland M.Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease[J].Int J Cardiol, 2013, 168 (4) :4117-4121." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122500344006&amp;v=MDA5MDBaKzhMREh3L29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhQmM9TmlmT2ZiSzlIOVBPcW85Rg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[22]</b>
                                        Thomas IC, Glassner-Kolmin C, Gomberg-Maitland M.Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease[J].Int J Cardiol, 2013, 168 (4) :4117-4121.
                                    </a>
                                </li>
                                <li id="47">


                                    <a id="bibliography_23" title="Li F, Xia W, Yuan S.Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease[J].Pediatr Cardiol, 2009, 30 (3) :363-366." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SSJD&amp;filename=SSJD00003508188&amp;v=MzI1OTFOWmVNSFkzazV6QmRoNGo5OVNYcVJyeG94Y01IN1I3cWRaK1p1RmlEbFU3elBJbHM9Tmo3QmFyTzRIdEhQcW85&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[23]</b>
                                        Li F, Xia W, Yuan S.Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease[J].Pediatr Cardiol, 2009, 30 (3) :363-366.
                                    </a>
                                </li>
                                <li id="49">


                                    <a id="bibliography_24" title="Scognamiglio G, Kempny A, Price LC, et al.C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value[J].Heart, 2014, 100 (17) :1335-1341." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value">
                                        <b>[24]</b>
                                        Scognamiglio G, Kempny A, Price LC, et al.C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value[J].Heart, 2014, 100 (17) :1335-1341.
                                    </a>
                                </li>
                                <li id="51">


                                    <a id="bibliography_25" title="Silvia Favilli .Gaia Spaziani.Advanced therapies in patients with congenital heartdisease-related pulmonary arterial hypertension:resultsfrom a long-term, single center, real-world follow-up[J].Intern Emerg Med, 2015, 10 (4) :445-450." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Advanced therapies in patients with congenital heart disease-related pulmonary arterial hypertension:results from a long-term,single center,real-world follow-up">
                                        <b>[25]</b>
                                        Silvia Favilli .Gaia Spaziani.Advanced therapies in patients with congenital heartdisease-related pulmonary arterial hypertension:resultsfrom a long-term, single center, real-world follow-up[J].Intern Emerg Med, 2015, 10 (4) :445-450.
                                    </a>
                                </li>
                                <li id="53">


                                    <a id="bibliography_26" title="Dimopoulos K, Inuzuka R, Goletto S, et al.Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension[J].Circulation, 2010, 121 (1) :20-25." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000037864&amp;v=MTg3NjIwVGFCYz1OaWZjWmJLNkg5SFByNDlGWk9nSUJIbzlvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[26]</b>
                                        Dimopoulos K, Inuzuka R, Goletto S, et al.Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension[J].Circulation, 2010, 121 (1) :20-25.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(02),256-259 DOI:10.3969/j.issn.1008-0074.2019.02.32            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>先天性心脏病相关性肺动脉高压的自然病程与预后影响因素</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%AD%99%E5%BD%AC%E5%B3%B0&amp;code=41352206&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">孙彬峰</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%90%B4%E7%82%B3%E7%A5%A5&amp;code=22929578&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">吴炳祥</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E5%93%88%E5%B0%94%E6%BB%A8%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%BA%8C%E5%8C%BB%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=1044277&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">哈尔滨医科大学附属第二医院心内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p>先天性心脏病相关性肺动脉高压 (CHD-PAH) 是肺动脉高压中的一大类, 患者不仅有肺血管疾病而且同时伴有心脏损伤。当先心病患者合并肺动脉高压时, 通常预后不良。了解CHD-PAH的自然病程以及预后影响因素, 对于诊断和治疗这类患者具有重要意义。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E8%84%8F%E7%BC%BA%E6%8D%9F%2C%20%E5%85%88%E5%A4%A9%E6%80%A7&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心脏缺损, 先天性;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%AB%98%E8%A1%80%E5%8E%8B%2C%20%E8%82%BA%E6%80%A7&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">高血压, 肺性;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%A2%84%E5%90%8E&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">预后;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *吴炳祥, E-mail:wubingxiang1964@163.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2017-12-05</p>

            </div>
                    <h1>Natural course and influencing factors of prognosis of congenital heart disease related pulmonary arterial hypertension</h1>
                    <h2>
                    <span>SUN Bin-feng</span>
                    <span>WU Bing-xiang</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Second Affiliated Hospital of Harbin Medical University</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p>Congenital heart disease related pulmonary arterial hypertension (CHD-PAH) is a large class of PAH, the patients possess pulmonary vascular disease as well as heart injury. When CHD complicated with PAH, their prognosis usually is poor. It is of important significance to understand natural course and influencing factors of prognosis of CHD-PAH for diagnosis and treatment of these patients.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Heart%20defects%2C%20congenital&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Heart defects, congenital;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Hypertension%2C%20pulmonary&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Hypertension, pulmonary;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Prognosis&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Prognosis;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    WU Bing-xiang, E-mail: wubingxiang1964@163.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2017-12-05</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="55">在美国, 成人先心病患者每年大约以5%的速度增长, 目前有超过100万成年人患有先心病, 大约有10%的病人会合并肺动脉高压<citation id="82" type="reference"><link href="3" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>;同样, 有30%未封堵的先心病患者会出现肺动脉高压。在合并肺动脉高压这部分病人中, 大约有接近50%的病人会发展为艾森曼格综合征 (ES) ;此时, 病人会出现右向左分流, 进行性发绀, 病情恶化<citation id="83" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。CONCOR在2011年登记了12624 名存活的成年先心病患者, 有5487 (44%) 患者有发展为肺动脉高压的风险。 随机样本包括了平均年龄 (40±15) 岁的1814例病人和135名肺动脉高压患者。研究表明肺动脉高压在先天性左向右分流CHD病人的流行率为7.4%。外科手术修补后肺动脉高压流行率高达5.7%。肺动脉高压在整个CHD人群的流行率为3.2%。随着先心病患者患病年龄增加, 肺动脉高压的发病率会逐年增加。研究发现30岁左向右分流先心病患者的肺动脉高压流行率为2.5%, 30～60岁流行率快速增加到10%。60～70岁肺动脉高压的流行率为13.8%, 70～79岁的流行率为35%, 80岁以上患者流行率为35%<citation id="84" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。</p>
                </div>
                <h3 id="56" name="56" class="anchor-tag"><b>1</b> CHD-PAH<b>诊断标准及分型</b></h3>
                <div class="p1">
                    <p id="57">先心病相关性肺动脉高压 (CHD-PAH) 血流动力学诊断标准:先心病患者, 在海平面, 静息状态下, 平均肺动脉压 (mPAP) ≥25mmHg, 肺毛细血管嵌压 (PCWP) ≤15mmHg, 肺血管阻力 (PVR) &gt;3wood units。</p>
                </div>
                <div class="p1">
                    <p id="58">CHD-PAH按解剖学-病理生理学分型可分为: (1) 三尖瓣前缺损 (房间隔缺损或肺静脉回流异常) ; (2) 三尖瓣后缺损 (室间隔缺损或动脉导管未闭) ; (3) 复杂解剖型 (房室间隔缺损或单心室) <citation id="85" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>。CHD-PAH按临床分型可分为: (1) 艾森曼格综合征; (2) 左向右分流 (可以封堵或不可以封堵) ; (3) 肺动脉高压合并先心病; (4) 术后肺动脉高压<citation id="86" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。</p>
                </div>
                <h3 id="59" name="59" class="anchor-tag"><b>2</b> CHD-PAH<b>自然病程与预后</b></h3>
                <h4 class="anchor-tag" id="60" name="60">2.1 艾森曼格综合征 (ES) </h4>
                <div class="p1">
                    <p id="61">据报道, 大约有50%未封堵的室间隔缺损 (VSD) 患者和大约10%未封堵的房间隔缺损 (ASD) 患者会发展为ES, ES的肺循环重塑机理还未完全阐明, 可能涉及到因素有血管收缩、炎症反应、血栓形成以及细胞增生和纤维化。此外, 血管活性物质分泌紊乱, 例如内皮素、血栓素等缩血管物质异常分泌增加, 也是促进肺血管阻力增加、血管重塑的重要因素<citation id="87" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>。以左向右分流先心病为例, 不管是心室还是心房水平的左向右分流, 都会出现肺血流量增加 (肺血管剪切力增加) ;肺血流量增加可以导致血管内皮功能损伤和血管重塑 (平滑肌、细胞外基质增生和血管内血栓形成) , 最终肺血管结构发生不可逆改变、PVR增加;引起左向右分流逆转为双向分流甚至是右向左分流, 此时患者会出现发绀。研究表明, ES患者的短期预后较好, 但整体寿命呈下降趋势, 简单缺损的患者较复杂缺损的患者生存率好<citation id="88" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。REVEAL对该中心2006年3月30日～2009年12月8日期间新近和以往诊断的3515名PAH 患者进行的一项临床研究表明 (其中包括1626特发性肺动脉高压 (IPAH) 患者和353名CHD-PAH患者) , ES患者的生存率较IPAH患者高<citation id="89" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。一项多中心参与的, 共77名ES患者进行了一项临床研究, 当ES患者状况良好 (无事件组) , 氧分压随着患病时间的延长会保持相对稳定;当患者身体机能下降时 (事件组) , 氧分压也在进行性下降;结果表明:氧分压下降会提示疾病预后不良。定义基线危险因素包括:NYHA≥III级、铁缺乏、右心室功能不全;结果显示:ES患者危险因素越多, 无事件生存率越低, 发生临床病情恶化的可能性越大;临床恶化定义为:NYHA心功能分级在II～III级、6min步行距离&lt;300m或休息时氧分压每年下降≥2%<citation id="90" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。</p>
                </div>
                <h4 class="anchor-tag" id="62" name="62">2.2 左向右分流先心病</h4>
                <div class="p1">
                    <p id="63">左向右分流相关性肺动脉高压的患者, 根据体—肺分流的程度, 可将 CHD-PAH患者分为动力PAH和阻力期PAH, 前者 (Qp/Qs≥1.5) 存在PAH, 但肺血管尚未出现严重病变此时行关闭缺损, 肺动脉压力常可降至正常。然而后者 (Qp/Qs&lt;1) 由于长期肺血管阻力的增加, 肺血管出现不可逆的改变, 如果此时关闭缺损, 则可能出现术后肺动脉压力不降反增或出现术后PAH, 所以对于此类患者应该综合评估肺血管的病变程度, 慎重选择治疗方案。</p>
                </div>
                <h4 class="anchor-tag" id="64" name="64">2.3 肺动脉高压合并先心病</h4>
                <div class="p1">
                    <p id="65">PAH合并CHD的这一类病人, 目前怀疑存在潜在的、额外的肺血管床先天性畸形, 临床特点和IPAH非常相似, 治疗和IPAH相似。手术关闭缺损是这类病人的禁忌症。博洛尼亚大学医院心血管研究所的一项临床研究数据表明:PAH合并CHD的15年生存率为66%, IPAH的15年生存率为38% 。PAH合并CHD的预后较IPAH好, 可能是因为这类病人伴有小缺损 (ASD直径&lt;2cm, VSD直径&lt;1cm) , 右向左分流可以增加左心血容量, 有效地限制了体循环减少<citation id="91" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。</p>
                </div>
                <h4 class="anchor-tag" id="66" name="66">2.4 术后肺动脉高压</h4>
                <div class="p1">
                    <p id="67">西班牙肺动脉高压研究中心的一项临床研究表明, 有四分之一的先心病术后患者会出现肺动脉高压。PAH可以在术后早期出现, 也可以在数月或数年后出现, 一旦出现, 很难纠正, 预后不良。目前认为这类患者可能存在有发展为PAH的遗传倾向。其预后与IPAH相似, 较ES病人差<citation id="92" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>。在许多案例中, 肺动脉高压往往在先心病封堵后被诊断, 但是此时肺血管已经存在不可逆的损伤<citation id="93" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>。</p>
                </div>
                <h3 id="68" name="68" class="anchor-tag"><b>3 影响</b>CHD-PAH<b>预后的相关因素</b></h3>
                <div class="p1">
                    <p id="69">影响CHD-PAH死亡率及预后主要包括BNP、血清肌钙蛋白、C反应蛋白 (CRP) 、三尖瓣环位移 (TAPSE) 值、右心房/左心房面积、右心室有效收缩时间/有效舒张时间、右心功能不全、6min步行距离等。</p>
                </div>
                <h4 class="anchor-tag" id="70" name="70">3.1 血清C反应蛋白对患者预后的影响</h4>
                <div class="p1">
                    <p id="71">英国皇家布朗普顿医院对该中心2000年6月～2012年的225名成人CHD-PAH患者进行了一项持续12年关于CRP对CHD-PAH患者死亡率及预后的回顾性临床研究。在追踪4.8年后, 有50名患者死亡。已故患者血清CRP11.5 mg/L (6.0～23.0) 显著高于生存患者的血清CRP4.0 mg/L (1.5～8.0) 。CHD-PAH患者血清 CRP&gt;10 mg/L, 死亡率会增加3倍 (HR 3.63, 95% CI 2.07～6.38, <i>P</i>&lt;0.001<citation id="94" type="reference"><link href="27" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。血清CRP可以简单、有效地预测患者的预后及死亡率, 应当把CRP常规纳入CHD-PAH患者危险分层中。</p>
                </div>
                <h4 class="anchor-tag" id="72" name="72">3.2 高敏肌钙蛋白T (hsTnT) 对患者预后的影响</h4>
                <div class="p1">
                    <p id="73">当先心病患者合并肺动脉高压后, 引起右心室功能衰竭, 右心室扩大, 压迫冠状动脉;心输出量下降, 心率代偿性加快, 心脏舒张期减少, 冠脉供血不足, 导致心肌缺血、损伤, 肌钙蛋白升高。阿姆斯特丹的学术医疗中心纳入2005年1月～2007年3月的31个成人CHD-PAH (86% ES) 患者, 其中不包括严重肾功能不全患者。入选的病人28个患者hsTnT值限制在 0.003 mg/L以下。8患者 (26%) hsTnT &gt;0.014 mg/L, hsTnT升高, 提示有心肌损伤。患者hsTnT升高, 纽约心功能分级在 III 或IV 级, NT-proBNP 较hsTnT正常水平高, 通常提示死亡率增加。NYHA I/II的CHD-PAH患者死亡率较低, hsTnT一般在正常范围内<citation id="95" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>。</p>
                </div>
                <h4 class="anchor-tag" id="74" name="74">3.3 BNP和 NT-proBNP对CHD-PAH患者预后的影响</h4>
                <div class="p1">
                    <p id="75">心肌细胞分泌BNP, 无论是全分子量或者NT-proBNP, 都是右心衰竭和 PAH患者死亡率公认的预后指标, 其中也包括各种已封堵和未封堵的CHD患者。成人和儿童CHD-PAH患者血清BNP都会升高。BNP升高程度可以反映由于肺血管疾病所引起的右心室壁应力增加和右心功能恶化程度<citation id="96" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。BNP浓度以及浓度的一系列变化似乎可以预测ES患者的生存率和/或住院指针, 当BNP浓度超过104 pg/ml往往提示患者死亡率增加<citation id="100" type="reference"><link href="33" rel="bibliography" /><link href="35" rel="bibliography" /><sup>[<a class="sup">16</a>,<a class="sup">17</a>]</sup></citation>, 浓度低于50 pg/ml预后较好<citation id="97" type="reference"><link href="37" rel="bibliography" /><sup>[<a class="sup">18</a>]</sup></citation>。一项多中心参与的, 入选2005年1月～2013年6月共91例成人CHD-PAH患者进行了一项临床研究;结果表明, 患者同时出现血清基线BNP水平≥500ng/L、TAPSE&lt;15mm的死亡率是83%, 与之相对应两者没有达到标准死亡率是20%<citation id="98" type="reference"><link href="39" rel="bibliography" /><sup>[<a class="sup">19</a>]</sup></citation>;同时有NT-proBNP≥500 ng/L 和 TAPSE&lt;15 mm 两个危险因素, 死亡率比没有这两个危险因素高9倍<citation id="99" type="reference"><link href="41" rel="bibliography" /><sup>[<a class="sup">20</a>]</sup></citation>。</p>
                </div>
                <h4 class="anchor-tag" id="76" name="76">3.4 部分超声心动图数值对CHD-PAH病人预后的影响</h4>
                <div class="p1">
                    <p id="77">超声心动图广泛的运用于诊断不同类型的肺动脉高压, 但是很少有数据用于CHD-PAH患者。最近, Moceri等连续的记录了181个ES患者的超声心动图数据, 不包括复杂CHD患者<citation id="101" type="reference"><link href="43" rel="bibliography" /><sup>[<a class="sup">21</a>]</sup></citation>。TAPSE&lt;15mm, 右心室有效的收缩时间/有效的舒张时间≥1.5, 右心房面积≥25cm<sup>2</sup>, 右心房面积/左心房面积≥1.5, 通常提示预后不良。</p>
                </div>
                <h3 id="78" name="78" class="anchor-tag"><b>4 靶向药物对</b>CHD-PAH<b>患者预后的影响</b></h3>
                <div class="p1">
                    <p id="79">前列环素 (PGI2) 对第一大类PAH患者的治疗是有效的。但是很少有人研究PGI2对成人CHD-PAH患者的治疗效果。一项来自芝加哥大学的临床研究:研究者对8名成人CHD-PAH使用PGI2连续治疗1年后, 和治疗前的基线水平相比, 患者肺动脉血氧饱和度较基线水平有所提高, 体循环压力或体循环血氧饱和度没有显著降低, 运动耐力增加, WHO心功能分级较基线水平没有下降。研究结果表明:CHD-PAH患者长期持续地接受PGI2治疗, 可以像第一大类PAH患者一样有效地改善血流动力学和临床症状。接受PGI2治疗后, 患者肺动脉血氧饱和度提高, 可以限制右向左分流<citation id="102" type="reference"><link href="45" rel="bibliography" /><sup>[<a class="sup">22</a>]</sup></citation>。相关文献提示:小至中等缺损左向右分流先心病合并肺动脉高压的患者在使用Rho激酶抑制剂后血流动力学指标明显改善<citation id="103" type="reference"><link href="47" rel="bibliography" /><sup>[<a class="sup">23</a>]</sup></citation>。患者在接受靶向治疗后6min步行距离较未使用靶向药物之前有所改善<citation id="104" type="reference"><link href="49" rel="bibliography" /><sup>[<a class="sup">24</a>]</sup></citation>, 心功能分级也会提高<citation id="105" type="reference"><link href="51" rel="bibliography" /><sup>[<a class="sup">25</a>]</sup></citation>, 靶向药物是治疗CHD-PAH的有效方法。据报道, 随着靶向药物治疗PAH, 各种类型PAH总死亡率减少了43%<citation id="106" type="reference"><link href="53" rel="bibliography" /><sup>[<a class="sup">26</a>]</sup></citation>。</p>
                </div>
                <h3 id="80" name="80" class="anchor-tag"><b>5 小 结</b></h3>
                <div class="p1">
                    <p id="81">CHD-PAH是导致先心病患者预后不良, 死亡率增加的主要原因;判断患者是否合并肺动脉高压以及严重程度对患者的生存质量、预后有重要影响。靶向药物应用于CHD-PAH患者可以部分改善患者的预后。在对CHD-PAH患者诊断及治疗中, 应强调早期诊断, 早期治疗, 最大程度改善患者预后。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="3">
                            <a id="bibliography_1" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Pulmonary arterial hypertension associated with congenital heart disease and eisenmenger syndrome:Current practice in pediatrics">

                                <b>[1]</b>Frank DB, Hanna BD.Pulmonary arterial hypertension associated with congenital heart dIsease and eisenmenger syndrome:current practice in pediatrics[J].Minerva Pediatr, 2015, 67 (2) ;169-185.
                            </a>
                        </p>
                        <p id="5">
                            <a id="bibliography_2" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Pulmonary Hypertension and Congenital Heart disease">

                                <b>[2]</b>Todds, Roth MD, Jamil A.Pulmonary Hypertension and Congenital Heart disease[J].Cardial Clin, 2016, 34:391-400.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14061600103106&amp;v=MDE2NTUvb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFCYz1OaWZPZmJLOEh0Zk5xWTlGWmVzTURYdw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>van Riel AC, Schuuring MJ, van Hessen ID, et al.Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification[J].Int J Cardiol, 2014, 174 (2) :299-305.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_4" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Pulmonary arterial hypertension associated with congenital heart disease:Comparison of clinical and anatomic-pathophysiologic classification">

                                <b>[4]</b>Ramjug S, Hussain N, Hurdman J, et al.Pulmonary arterial hypertension associated with congenital heart disease:Comparison of clinical and anatomic-pathophysiologic classification[J].J Heart Lung Transplant, 2016, 35 (5) :610-618.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_5" target="_blank" href="">

                                <b>[5]</b>5<sup>th </sup>world symposium on Pulmonary Hypertension, Nice, 2013.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100340574&amp;v=MTc0MTBmT2ZiSzdIdERPcm85RlorOFBDWHM5b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFCYz1OaQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>Beghetti M, Galiè N.Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension[J].J Am Coll Cardiol, 2009, 53 (9) :733-740.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_7" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study">

                                <b>[7]</b>Diller GP, Dimopoulos K, Broberg CS, et al.Presentation, survival prospects, and predictors of death in Eisenmenger syndrome:a combined retrospective and case-control study[J].Eur Heart J, 2006, 27 (14) :1737-1742.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_8" >
                                    <b>[8]</b>
                                Barst RJ, Ivy DD, Foreman AJ, et al.Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry) [J].Am J Cardiol, 2014, 113 (1) :147-155.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000032558&amp;v=MDYzNTlpclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFCYz1OaWZjWmJLNkg5SFByNDlGWk9nTkNYa3hvQk1UNlQ0UFFILw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>Diller GP, Dimopoulos K, Okonko D, et al.Exercise intolerance in adult congenital heart disease:comparative severity, correlates, and prognostic implication[J].Circulation, 2005, 112 (6) :828-835.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_10" >
                                    <b>[10]</b>
                                Manes A, Palazzini M, Leci E, et al.Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease:a comparison between clinical subgroups[J].Eur Heart J, 2014, 35 (11) :716-724.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122500347100&amp;v=Mjc2MjRaKzhJRFh3NW9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhQmM9TmlmT2ZiSzlIOVBPcW85Rg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>Alonso-Gonzalez R, Lopez-Guarch CJ, Subirana-Domenech MT, et al.Pulmonary hypertension and congenital heart disease:An insight from the REHAP National Registry[J].Int J Cardiol, 2015, 184:717-723.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_12" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease:a comparison between clinical subgroups">

                                <b>[12]</b>Manes A, Palazzini M, Leci E, et al.Current era survival of patients with pulmonary arterial hypertension associated withcongenital heart disease:a comparison between clinical subgroups[J].Eur Heart J, 2014, 35 (11) :716-724.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_13" >
                                    <b>[13]</b>
                                Scognamiglio G, Kempny A, Price LC, et al.C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value[J].Heart, 2014, 100 (17) :1335-1341.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD13120900000453&amp;v=MjA1MzdpZmNhcks3SDlQTXBvOUZaT3NQQ0hrNm9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhQmM9Tg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>Schuuring MJ, van Riel AC, Vis JC, et al.High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease[J].Congenit Heart Dis, 2013, 8 (6) :520-526
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702187489&amp;v=MjE1NDhJRjBUYUJjPU5pZk9mYks3SHRETnFJOUhaZU1JQ0hRd29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>Maeda K, Tsutamoto T, Wada A, et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction[J].Am Heart J, 1998, 135 (SPt 1) :825-832.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_16" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702166217&amp;v=MDY0ODMrb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFCYz1OaWZPZmJLN0h0RE5xSTlIWmUwSkRuMA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[16]</b>Reardon LC, Williams RJ, Houser LS, et al.Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome[J].Am J Cardiol, 2012, 110 (10) :1523-1526.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_17" target="_blank" href="http://scholar.cnki.net/result.aspx?q=B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy">

                                <b>[17]</b>Diller G-P, Alonso-Gonzalez R, Kempny A, et al.B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients:predictive value and response to disease targeting therapy[J].Heart, 2012, 98 (19) :736-742.
                            </a>
                        </p>
                        <p id="37">
                            <a id="bibliography_18" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15120400079031&amp;v=Mjc1OTVsVXJmSUlGMFRhQmM9TmlmT2ZiSzlIOVBNcTQ5RlpPd0dESDg0b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[18]</b>Barst RJ, Ivy DD, Foreman AJ, et al.Four- and seven-year outcomes of patients with congenital heart disease — associated pulmonary arterial hypertension (from the REVEAL registry) [J].Am J Cardiol, 2014, 113 (1) :147-155.
                            </a>
                        </p>
                        <p id="39">
                            <a id="bibliography_19" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122500346832&amp;v=MDQwNDFUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFCYz1OaWZPZmJLOUg5UE9xbzlGWis4SkJIODdvQk1UNg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[19]</b>Schuuring MJ, van Riel AC, Vis JC, et al.New predictors of mortality in adults with congenital heart disease and pulmonary hypertension:Midterm outcome of a prospective study[J].Int J Cardiol, 2015, 181 () :270-276.
                            </a>
                        </p>
                        <p id="41">
                            <a id="bibliography_20" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK120927000383&amp;v=MDM2MDJnSER4TTh6eFVTbURkOVNIN24zeEU5ZmJ2bktyaWZaZVp2RnludFU3L0xKMXdSTmlmY1piSzZIdGpPcUk5RlpP&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[20]</b>Moceri P, Dimopoulos K, Liodakis E, et al.Echocardiographic predictors of outcome in Eisenmenger syndrome[J].Circulation, 2012, 126 (12) :1461-1468.
                            </a>
                        </p>
                        <p id="43">
                            <a id="bibliography_21" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension">

                                <b>[21]</b>D′Alto M, Dimopoulos K, Budts W, et al.Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension[J].Heart, 2016, 102 (12) :910-918.
                            </a>
                        </p>
                        <p id="45">
                            <a id="bibliography_22" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES15122500344006&amp;v=MjQzNTBLOUg5UE9xbzlGWis4TERIdy9vQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYUJjPU5pZk9mYg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[22]</b>Thomas IC, Glassner-Kolmin C, Gomberg-Maitland M.Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease[J].Int J Cardiol, 2013, 168 (4) :4117-4121.
                            </a>
                        </p>
                        <p id="47">
                            <a id="bibliography_23" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SSJD&amp;filename=SSJD00003508188&amp;v=MTAyOTF1RmlEbFU3elBJbHM9Tmo3QmFyTzRIdEhQcW85TlplTUhZM2s1ekJkaDRqOTlTWHFScnhveGNNSDdSN3FkWita&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[23]</b>Li F, Xia W, Yuan S.Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease[J].Pediatr Cardiol, 2009, 30 (3) :363-366.
                            </a>
                        </p>
                        <p id="49">
                            <a id="bibliography_24" target="_blank" href="http://scholar.cnki.net/result.aspx?q=C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value">

                                <b>[24]</b>Scognamiglio G, Kempny A, Price LC, et al.C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value[J].Heart, 2014, 100 (17) :1335-1341.
                            </a>
                        </p>
                        <p id="51">
                            <a id="bibliography_25" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Advanced therapies in patients with congenital heart disease-related pulmonary arterial hypertension:results from a long-term,single center,real-world follow-up">

                                <b>[25]</b>Silvia Favilli .Gaia Spaziani.Advanced therapies in patients with congenital heartdisease-related pulmonary arterial hypertension:resultsfrom a long-term, single center, real-world follow-up[J].Intern Emerg Med, 2015, 10 (4) :445-450.
                            </a>
                        </p>
                        <p id="53">
                            <a id="bibliography_26" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000037864&amp;v=MzA4MzZRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFCYz1OaWZjWmJLNkg5SFByNDlGWk9nSUJIbzlvQk1UNlQ0UA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[26]</b>Dimopoulos K, Inuzuka R, Goletto S, et al.Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension[J].Circulation, 2010, 121 (1) :20-25.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201902032" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902032&amp;v=MDg5MDlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am1WTDNOUFRYTVpiRzRIOWpNclk5R1pvUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
